TGFB1 and breast carcinoma: Conversely, blockade of this signalization pathway has been associated with significant inhibition of human basal-like breast cancer metastasis [90], while TGFB-targeted clinical/preclinical studies in breast cancer have shown delayed tumor growth [91].